Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Q Eichacker

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Transfusion Medicine (Oxford, England)|April 21, 2018
Risks of restrictive red blood cell transfusion strategies in patients with cardiovascular disease (CVD): a meta-analysisI Cortés-Puch, B M Wiley, J Sun, et al.
The American Review of Respiratory Disease|May 1, 1992
Leukocyte CD11b/18 antigen-directed monoclonal antibody improves early survival and decreases hypoxemia in dogs challenged with tumor necrosis factorP Q Eichacker, A Farese, W D Hoffman, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|June 1, 1996
Controlled trials of rG-CSF and CD11b-directed MAb during hyperoxia and E. coli pneumonia in ratsB D Freeman, R Correa, W Karzai, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|January 7, 1998
rG-CSF reduces endotoxemia and improves survival during E. coli pneumoniaB D Freeman, Z Quezado, F Zeni, et al.
The Journal of Experimental Medicine|February 1, 1994
The third component of complement protects against Escherichia coli endotoxin-induced shock and multiple organ failureZ M Quezado, W D Hoffman, J A Winkelstein, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|April 1, 1993
Leukocyte CD18 monoclonal antibody worsens endotoxemia and cardiovascular injury in canines with septic shockP Q Eichacker, W D Hoffman, A Farese, et al.
The Journal of Experimental Medicine|March 1, 1989
Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shockC Natanson, P W Eichenholz, R L Danner, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|September 15, 2001
Acute G-CSF therapy is not protective during lethal E. coli sepsisZ Quezado, C Parent, W Karzai, et al.
The Journal of Infectious Diseases|February 1, 1993
Therapeutic trial of lipid X in a canine model of septic shockR L Danner, P Q Eichacker, M E Doerfler, et al.
Critical Care Medicine|May 20, 1998
Response of the septic vasculature to prolonged vasopressor therapy with N(omega)-monomethyl-L-arginine and epinephrine in caninesB D Freeman, F Zeni, S M Banks, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Transfusion Medicine (Oxford, England)|April 21, 2018
Risks of restrictive red blood cell transfusion strategies in patients with cardiovascular disease (CVD): a meta-analysisI Cortés-Puch, B M Wiley, J Sun, et al.
The American Review of Respiratory Disease|May 1, 1992
Leukocyte CD11b/18 antigen-directed monoclonal antibody improves early survival and decreases hypoxemia in dogs challenged with tumor necrosis factorP Q Eichacker, A Farese, W D Hoffman, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|June 1, 1996
Controlled trials of rG-CSF and CD11b-directed MAb during hyperoxia and E. coli pneumonia in ratsB D Freeman, R Correa, W Karzai, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|January 7, 1998
rG-CSF reduces endotoxemia and improves survival during E. coli pneumoniaB D Freeman, Z Quezado, F Zeni, et al.
The Journal of Experimental Medicine|February 1, 1994
The third component of complement protects against Escherichia coli endotoxin-induced shock and multiple organ failureZ M Quezado, W D Hoffman, J A Winkelstein, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|April 1, 1993
Leukocyte CD18 monoclonal antibody worsens endotoxemia and cardiovascular injury in canines with septic shockP Q Eichacker, W D Hoffman, A Farese, et al.
The Journal of Experimental Medicine|March 1, 1989
Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shockC Natanson, P W Eichenholz, R L Danner, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|September 15, 2001
Acute G-CSF therapy is not protective during lethal E. coli sepsisZ Quezado, C Parent, W Karzai, et al.
The Journal of Infectious Diseases|February 1, 1993
Therapeutic trial of lipid X in a canine model of septic shockR L Danner, P Q Eichacker, M E Doerfler, et al.
Critical Care Medicine|May 20, 1998
Response of the septic vasculature to prolonged vasopressor therapy with N(omega)-monomethyl-L-arginine and epinephrine in caninesB D Freeman, F Zeni, S M Banks, et al.
Pageof 4